Cargando…

Clinical features of drug-induced Parkinsonism

Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiraiwa, Nobuko, Tamaoka, Akira, Ohkoshi, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322048/
https://www.ncbi.nlm.nih.gov/pubmed/30687468
http://dx.doi.org/10.4081/ni.2018.7877
_version_ 1783385547418370048
author Shiraiwa, Nobuko
Tamaoka, Akira
Ohkoshi, Norio
author_facet Shiraiwa, Nobuko
Tamaoka, Akira
Ohkoshi, Norio
author_sort Shiraiwa, Nobuko
collection PubMed
description Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson’s disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs.
format Online
Article
Text
id pubmed-6322048
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-63220482019-01-25 Clinical features of drug-induced Parkinsonism Shiraiwa, Nobuko Tamaoka, Akira Ohkoshi, Norio Neurol Int Article Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson’s disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs. PAGEPress Publications, Pavia, Italy 2018-12-20 /pmc/articles/PMC6322048/ /pubmed/30687468 http://dx.doi.org/10.4081/ni.2018.7877 Text en ©Copyright N. Shiraiwa et al., 2018 http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Article
Shiraiwa, Nobuko
Tamaoka, Akira
Ohkoshi, Norio
Clinical features of drug-induced Parkinsonism
title Clinical features of drug-induced Parkinsonism
title_full Clinical features of drug-induced Parkinsonism
title_fullStr Clinical features of drug-induced Parkinsonism
title_full_unstemmed Clinical features of drug-induced Parkinsonism
title_short Clinical features of drug-induced Parkinsonism
title_sort clinical features of drug-induced parkinsonism
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322048/
https://www.ncbi.nlm.nih.gov/pubmed/30687468
http://dx.doi.org/10.4081/ni.2018.7877
work_keys_str_mv AT shiraiwanobuko clinicalfeaturesofdruginducedparkinsonism
AT tamaokaakira clinicalfeaturesofdruginducedparkinsonism
AT ohkoshinorio clinicalfeaturesofdruginducedparkinsonism